Diabetic Peripheral Neuropathy News and Research

RSS
According to the National Institute of Diabetes & Digestive & Kidney Diseases, approximately half of those with diabetes have some form of nerve damage, or neuropathy, but not all will develop symptoms. While nerve problems can occur at any time, the highest rates are among those who have had diabetes for at least 25 years. People who have had problems controlling their blood sugar levels, have high blood pressure, are overweight, have high levels of blood fat, or are over the age of 40, may also have a greater risk of developing diabetic peripheral neuropathy. Symptoms can include numbness, tingling or pain and weakness in the toes, feet, legs, hands, arms and fingers. These symptoms are often worse at night.
Diabetic nerve pain: Most bothersome complication of diabetes

Diabetic nerve pain: Most bothersome complication of diabetes

New online educational forum for medical professionals from HMP Communications

New online educational forum for medical professionals from HMP Communications

Biochemics and Pacific Pharmaceutical to collaborate on skin products

Biochemics and Pacific Pharmaceutical to collaborate on skin products

Lilly resubmits Cymbalta supplemental NDA for chronic pain to FDA

Lilly resubmits Cymbalta supplemental NDA for chronic pain to FDA

Pregabalin shows potential as treatment for hot flashes

Pregabalin shows potential as treatment for hot flashes

Diabetics with previous foot ulcers may be able to participate in walking program

Diabetics with previous foot ulcers may be able to participate in walking program

ReBuilder Medical Technologies secures license to manufacture electronic molluscum contagiosum treatment system

ReBuilder Medical Technologies secures license to manufacture electronic molluscum contagiosum treatment system

EpiCept to conduct Phase III study of EpiCept NP-1 for treatment of chemotherapy induced peripheral neuropathy

EpiCept to conduct Phase III study of EpiCept NP-1 for treatment of chemotherapy induced peripheral neuropathy

Sangamo BioSciences starts phase 2 trial of therapy diabetic neuropathy

Sangamo BioSciences starts phase 2 trial of therapy diabetic neuropathy

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Drug that reduces the pain of fibromyalgia and improves sleep

Drug that reduces the pain of fibromyalgia and improves sleep

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

Cymbalta approved for diabetic peripheral neuropathy pain

Cymbalta approved for diabetic peripheral neuropathy pain

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Risk Assessment of Diabetic Retiopathy Improved by Screening Methods

Risk Assessment of Diabetic Retiopathy Improved by Screening Methods